The 10^th CAR-TCR Summit features a speaker faculty of 100+ experts, including investors and partnering leaders, founders and c-level leaders, and pharma and biotech leaders, and pioneering academics.

Here’s a snapshot of the faculty:

• Aaron Cooper, Vice President, Early Discovery, Arsenal Bio
• Mark Cobbold, Senior Vice President Immuno-Oncology, Discovery & Cell Therapy Oncology, AstraZeneca
• Peter Gergely, Global Head of Immunology, Translational Medicine, Novartis
• Alexis Melton, Director, Early Clinical Development Haematology & Cell Therapy, Bristol Myers Squibb
• Anna Truppel-Hartmann, Chief Medical Officer, KSQ Therapeutics
• Naji Gehchan, Chief Medical & Development Officer, Kyverna Therapeutics
• Christopher Tan, Executive Director, Search & Evaluation Business Development & Licensing, Merck
• Kingyin Lee, Head of Clinical Trials, MHRA
• Nan Zhang, Chief, Cell Therapy Manufacturing Section, NIH
• Tom Kowski, Vice President, Analytical Development, Umoja Biopharma

See the full speaker line-up here.